GENTILINI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 10.386
EU - Europa 4.771
AS - Asia 859
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
OC - Oceania 1
Totale 16.042
Nazione #
US - Stati Uniti d'America 10.356
SE - Svezia 1.002
IE - Irlanda 978
PL - Polonia 795
UA - Ucraina 577
IT - Italia 483
HK - Hong Kong 451
DE - Germania 348
FI - Finlandia 268
CN - Cina 164
GB - Regno Unito 155
TR - Turchia 136
CH - Svizzera 71
JO - Giordania 46
FR - Francia 35
CA - Canada 29
SG - Singapore 25
BE - Belgio 19
RU - Federazione Russa 19
IN - India 16
SC - Seychelles 15
NL - Olanda 14
VN - Vietnam 12
KR - Corea 7
EU - Europa 4
EG - Egitto 2
ES - Italia 2
MU - Mauritius 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CL - Cile 1
EE - Estonia 1
IR - Iran 1
MX - Messico 1
NO - Norvegia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 16.042
Città #
Fairfield 1.224
Chandler 1.085
Dublin 977
Jacksonville 918
Warsaw 794
Woodbridge 594
Ashburn 581
Cambridge 565
Seattle 545
Wilmington 453
Houston 439
Princeton 264
Ann Arbor 250
Hong Kong 229
Boardman 200
Boston 190
Buffalo 185
Medford 124
Lawrence 121
Altamura 116
Izmir 107
Beijing 96
San Diego 72
Bern 70
Norwalk 66
Dearborn 47
Milan 37
Andover 32
Hillsboro 31
Falls Church 30
Florence 29
Kent 29
Shanghai 29
Auburn Hills 27
New York 27
Bremen 25
Frankfurt Am Main 24
Singapore 24
West Jordan 22
Toronto 21
Brussels 19
Verona 19
Los Angeles 18
Washington 17
Salerno 15
Guangzhou 11
Dong Ket 10
Laurel 9
Rome 9
London 7
Saint Petersburg 7
Nanjing 6
Philadelphia 6
Pune 6
Redmond 6
Bagno a Ripoli 5
Kunming 5
Phoenix 5
Tappahannock 5
Catania 4
Changsha 4
Las Vegas 4
San Mateo 4
Caserta 3
Grevenbroich 3
Old Bridge 3
Redwood City 3
Riardo 3
Seoul 3
Brescia 2
Cairo 2
Chicago 2
Empoli 2
Helsinki 2
Kolkata 2
Lappeenranta 2
Meppel 2
Modena 2
Modica 2
Montréal 2
Naaldwijk 2
New Delhi 2
Rivoli 2
Rufina 2
Salamanca 2
Southwark 2
Taranto 2
Torino 2
Agliana 1
Ardabil 1
Arezzo 1
Ashford 1
Atlanta 1
Augusta 1
Banbridge 1
Bangkok 1
Bari 1
Belgrade 1
Bergamo 1
Bologna 1
Totale 10.968
Nome #
Serum hepatitis delta virus RNA in patients with delta hepatitis and in liver graft recipients 1.103
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 237
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 221
Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells 214
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 208
The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx 207
Fat-storing cells as liver-specific pericytes: spatial dynamic of agonist-stimulated intracellular calcium transients. 192
Bile acid inhibition of p-glycoprotein mediated transport in multidrug resistant cells and rat liver canalicular membrane vesicles 113
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 113
SURVIVAL AND PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED BY PERCUTANEOUS ETHANOL INJECTION: A 10-YEAR EXPERIENCE. 111
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 106
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 102
Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells 101
Amplification of hepatitis delta virus RNA sequences by polymerase chain reaction: a tool for viral detection and cloning 100
Defective aggregation in cirrhosis is independent of in vivo platelet activation. 100
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 98
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 97
Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients 93
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 93
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 92
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 92
Torasemide in the treatment of patients with cirrhosis and ascites. 91
Patterns and mechanisms of hepatitis B/hepatitis D reinfection after liver transplantation 90
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 88
Ascites and hepatorenal syndrome 87
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 87
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 87
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 86
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 86
T(14;18) translocation in chronic hepatitis C virus infection 85
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 83
Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis 82
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 82
Infection of peripheral mononuclear blood cells by hepatitis C virus 81
Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. 81
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 81
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 81
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 81
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 81
Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. 81
Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure. 80
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 80
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation 79
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. 79
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. 79
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 79
Pathogenesis and management of the hepatorenal syndrome. 79
Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. 78
Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. 77
Loop diuretic therapy in liver cirrhosis with ascites 77
Pathogenesis and treatment of ascites in hepatic cirrhosis. 77
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 77
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 76
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 76
Expression of platelet-derived growth factor in a model of acute liver injury. 75
Renal functional impairment and sodium retention in liver cirrhosis. 75
Uveitis in autoimmune hepatitis: a case report. 75
Polymerase chain reaction for hepatitis delta virus RNA identification and characterization 75
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 75
Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells. 75
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 74
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 74
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role 74
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 74
Pathogenesis and treatment of ascites in hepatic cirrhosis. 74
Respiratory mechanics in patients with tense cirrhotic ascites. 74
The cellular and molecular basis of liver fibrogenesis. 73
Fibrogenesi epatica: valutazione dell'espressione genica di citochine fibrogeniche e dei tipi più rappresentanti di collagene. 73
Multiple biological effects of endothelin-1 in fat-storing cells isolated from human liver. 73
Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. 73
Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. 73
Analysis of HCV persistence in patients with sustained virological response 72
CARDIOVASCULAR EFFECTS OF CANRENONE IN PRE-ASCITIC CIRRHOSIS. 72
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 72
Changes in the production of nitric oxide and superoxide by inflammatory cells in liver cirrhosis. 72
Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration. 71
Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists 71
Hepatic lipid peroxidation and aldehyde dehydrogenase activity in alcoholic and non alcoholic liver disease. 70
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 70
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection 69
Hemodynamic, renal and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 69
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 69
Molecular mechanism underlying impaired platelet responsiveness in liver cirrhosis 69
Vascular reserve in the lower limbs of cirrhotic patients: a duplex Doppler ultrasound study. 68
Hepatitis C virus lymphotropism and possible pathogenetic implications 68
HCV infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. 68
HCV INFECTION OF PERIPHERAL AND LIVER MONONUCLEAR-CELLS - PATHOGENIC IMPLICATIONS 68
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 67
Systemic haemodynamics, renal and platelet function during chronic propranolol ADMINISTRATION IN PATIENTS WITH COMPENSATED CIRRHOSIS 67
HNE interacts directly with JNK isoforms in human hepatic stellate cells 66
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour 66
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 66
Hepatorenal syndrome and its treatment today. 66
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia 65
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 65
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. 65
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 65
Interferon-alpha in mixed cryoglobulinemia patients: a randomized crossover controlled trial 64
Interstitial lung fibrosis in patients with hepatitis C virus infection 63
Impaired superoxide anion, platelet-activating factor, and leukotriene B4synthesis by neutrophils in cirrhosis. 63
Totale 9.712
Categoria #
all - tutte 43.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.025 0 0 0 0 0 0 0 0 0 0 580 445
2019/20203.077 251 260 63 327 282 414 325 413 260 174 262 46
2020/20212.068 202 88 213 194 57 336 37 197 151 279 134 180
2021/20221.574 25 192 46 72 42 51 49 80 66 42 380 529
2022/20234.195 429 428 201 320 435 841 572 250 469 28 120 102
2023/20241.217 65 180 278 79 77 147 35 263 23 31 39 0
Totale 16.086